Corbin, A E <br/><br/>
PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effects.  [electronic resource] 

 -  Neuropharmacology  Apr 2000 
 - 1211-21 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0028-3908 
<br/><br/><label>Standard No.: </label>10.1016/s0028-3908(99)00214-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Anxiety Agents--pharmacology<br/>Antidepressive Agents--pharmacology<br/>Antipsychotic Agents--pharmacology<br/>Avoidance Learning--drug effects<br/>Basal Ganglia Diseases--chemically induced<br/>Behavior, Animal--drug effects<br/>Catalepsy--chemically induced<br/>Cebus<br/>Conflict, Psychological<br/>Dopamine Agonists--pharmacology<br/>Male<br/>Mice<br/>Motor Activity--drug effects<br/>Piperazines--pharmacology<br/>Pyrimidines--pharmacology<br/>Rats<br/>Rats, Inbred WKY<br/>Rats, Sprague-Dawley<br/>Rats, Wistar<br/>Receptors, Dopamine D2--agonists<br/>Receptors, Dopamine D3<br/>Receptors, Serotonin--drug effects<br/>Receptors, Serotonin, 5-HT1<br/>Saimiri<br/>Serotonin Receptor Agonists--metabolism